Zobrazeno 1 - 10
of 91
pro vyhledávání: '"G. Caleb Alexander"'
Publikováno v:
Addiction. 117:969-976
BACKGROUND AND AIMS Despite prescribing declines between 2011 and 2019, opioid morbidity and mortality in the United States continued to rise during this period. We estimated the relationship between opioid prescribing, opioid use disorder (OUD) and
Autor:
Jenny S. Guadamuz, Jocelyn Wilder, Morgane C Mouslim, Shannon N. Zenk, Dima M. Qato, G. Caleb Alexander
Publikováno v:
Health Affairs. 40:802-811
The accessibility of pharmacies may be an overlooked contributor to persistent racial and ethnic disparities in the use of prescription medications and essential health care services within urban areas in the US. We examined the availability and geog
Autor:
G. Caleb Alexander, Jenny S. Guadamuz, Ben Urick, Dima M. Qato, Sun Choi, Carter D. McCormick
Publikováno v:
Journal of the American Pharmacists Association. 61:e100-e113
Telepharmacies, which dispense medications on-site under the supervision of an off-site pharmacist using telecommunication technologies, have been proposed as a means to ameliorate the impact of pharmacy closures and improve access to medications.To
Publikováno v:
Psychiatric Services. 72:77-80
This study aimed to quantify the association between pharmaceutical industry payments to physicians for pimavanserin and both pimavanserin prescription volume and Medicare expenditures.This retrospective cross-sectional study used 2016 and 2017 data
Autor:
Jennifer K. Chen, Thomas J. Moore, Kristin Meek, James Heyward, Peter Lurie, G. Caleb Alexander
Publikováno v:
Annals of Internal Medicine. 173:956-963
BACKGROUND Little is known about the evidence required by the U.S. Food and Drug Administration (FDA) for new approvals of opioid analgesics. OBJECTIVE To characterize the quality of safety and efficacy data in new drug applications (NDAs) for opioid
Publikováno v:
Value Health
Objectives To estimate the effect of filgrastim-sndz market entry on patient out-of-pocket costs and claim payments for filgrastim products. Methods This study used a single interrupted time series design with longitudinal, nationally representative,
Autor:
Xia Wang, Dora H. Lin, H Nab, Edward R Hammond, Jonothan C. Tierce, Barnabas Desta, Irene B. Murimi-Worstell, G. Caleb Alexander, H. Kan
Publikováno v:
The Journal of Rheumatology. 48:385-393
Objective.To quantify healthcare utilization and costs by disease severity for patients with systemic lupus erythematosus (SLE) in the United States.Methods.We conducted descriptive analyses of Humedica electronic health record (EHR) data from 2011 t
Publikováno v:
Epidemiol Rev
The opioid overdose epidemic is typically described as having occurred in 3 waves, with morbidity and mortality accruing over time principally from prescription opioids (1999–2010), heroin (2011–2013), and illicit fentanyl and other synthetic opi
Autor:
Mark C. Bicket, Suzanne A. Nesbit, Susan Hutfless, Christopher L. Wu, Gabriel A. Brat, G. Caleb Alexander
Publikováno v:
American Journal of Health-System Pharmacy. 76:1403-1412
PurposeMillions of Americans who undergo surgical procedures receive opioid prescriptions as they return home. While some derive great benefit from these medicines, others experience adverse events, convert to chronic opioid use, or have unused medic
Autor:
G. Caleb Alexander, Francis B. Palumbo, Eberechukwu Onukwugha, Beth Ann Griffin, Donna Harrington, Linda Simoni-Wastila, Patience Moyo
Publikováno v:
Health Serv Res
OBJECTIVE: To estimate the impact of implementing prescription drug monitoring program (PDMP) best practices on prescription opioid use. DATA SOURCES: 2007–2012 Medicare claims for noncancer pain patients, and PDMP attributes from the Prescription